Immunosuppressive therapy of severe aplastic anemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000728:Androgens / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002986:Clinical Trials as Topic; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D010110:Oxymetholone / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology*
D000728:Androgens; D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D010110:Oxymetholone